177 related articles for article (PubMed ID: 32648994)
21. KLF6 Induces Apoptosis in Human Lens Epithelial Cells Through the ATF4-ATF3-CHOP Axis.
Tian F; Zhao J; Bu S; Teng H; Yang J; Zhang X; Li X; Dong L
Drug Des Devel Ther; 2020; 14():1041-1055. PubMed ID: 32210535
[TBL] [Abstract][Full Text] [Related]
22. The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA.
Soderquist R; Pletnev AA; Danilov AV; Eastman A
Apoptosis; 2014 Jan; 19(1):201-9. PubMed ID: 24072590
[TBL] [Abstract][Full Text] [Related]
23. Promise of combining a Bcl-2 family inhibitor with bortezomib or SAHA for adult T-cell leukemia/lymphoma.
Kunami N; Katsuya H; Nogami R; Ishitsuka K; Tamura K
Anticancer Res; 2014 Oct; 34(10):5287-94. PubMed ID: 25275021
[TBL] [Abstract][Full Text] [Related]
24. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
25. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
[TBL] [Abstract][Full Text] [Related]
26. The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells
Wierz M; Pierson S; Chouha N; Désaubry L; François JH; Berchem G; Paggetti J; Moussay E
Haematologica; 2018 Apr; 103(4):e154-e157. PubMed ID: 29305413
[No Abstract] [Full Text] [Related]
27. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
29. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
30. The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.
Weller S; Toennießen A; Schaefer B; Beigl T; Muenchow A; Böpple K; Hofmann U; Gillissen BF; Aulitzky WE; Kopp HG; Essmann F
Cell Death Discov; 2022 Apr; 8(1):215. PubMed ID: 35443750
[TBL] [Abstract][Full Text] [Related]
31. Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737.
Raats DA; de Bruijn MT; Steller EJ; Emmink BL; Borel-Rinkes IH; Kranenburg O
Cell Oncol (Dordr); 2011 Aug; 34(4):307-13. PubMed ID: 21468686
[TBL] [Abstract][Full Text] [Related]
32. A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4.
Evstafieva AG; Garaeva AA; Khutornenko AA; Klepikova AV; Logacheva MD; Penin AA; Novakovsky GE; Kovaleva IE; Chumakov PM
Cell Death Dis; 2014 Nov; 5(11):e1511. PubMed ID: 25375376
[TBL] [Abstract][Full Text] [Related]
33. PAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis.
Marshall AD; Picchione F; Geltink RI; Grosveld GC
Neoplasia; 2013 Jul; 15(7):738-48. PubMed ID: 23814486
[TBL] [Abstract][Full Text] [Related]
34. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.
Lucas KM; Mohana-Kumaran N; Lau D; Zhang XD; Hersey P; Huang DC; Weninger W; Haass NK; Allen JD
Clin Cancer Res; 2012 Feb; 18(3):783-95. PubMed ID: 22173547
[TBL] [Abstract][Full Text] [Related]
35. ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
Airiau K; Mahon FX; Josselin M; Jeanneteau M; Turcq B; Belloc F
Exp Hematol; 2012 May; 40(5):367-78.e2. PubMed ID: 22240609
[TBL] [Abstract][Full Text] [Related]
36. Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.
Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
Blood Cancer J; 2015 Dec; 5(12):e373. PubMed ID: 26636288
[TBL] [Abstract][Full Text] [Related]
37. Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells.
Joo JH; Ueda E; Bortner CD; Yang XP; Liao G; Jetten AM
Biochem Pharmacol; 2015 Oct; 97(3):256-68. PubMed ID: 26275811
[TBL] [Abstract][Full Text] [Related]
38. Mild thermotolerance induced at 40 °C protects cells against hyperthermia-induced pro-apoptotic changes in Bcl-2 family proteins.
Glory A; Bettaieb A; Averill-Bates DA
Int J Hyperthermia; 2014 Nov; 30(7):502-12. PubMed ID: 25354679
[TBL] [Abstract][Full Text] [Related]
39. 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.
Jin S; Cojocari D; Purkal JJ; Popovic R; Talaty NN; Xiao Y; Solomon LR; Boghaert ER; Leverson JD; Phillips DC
Clin Cancer Res; 2020 Jul; 26(13):3371-3383. PubMed ID: 32054729
[TBL] [Abstract][Full Text] [Related]
40. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S
Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]